Companion apps have revolutionized drug launches, making them more accessible to patients. We see more patients adhering to their medications while researchers receive more accurate information on how the drug impacts people.
PRA worked with a sponsor on their companion app for prescribers and patients for HGH. The app led to three outcomes:
- Physician preference for that drug
- Increased market adoption in a crowded market
- Increased patient adherence to the drug
To reach these outcomes, make sure to incorporate these five things into the companion app for your upcoming drug launch.
1. Patient-Centric Format
Patients are at the core of treatments and understanding how they think, interact and react to digital applications is critical. That means developers and pharma marketing leaders must understand how the patients think.
Accomplish this by testing the app on a small group before debuting it to the masses. Putting the app in front of patients will provide insight into how easily users can navigate the app. An app might seem fantastic and functional during design, but it might not work for them when it reaches patients.
Knowing this information early on in the development process will save money and make the project more efficient. To create a better product, app developers should keep patients in mind from the beginning and involve them in the creation process.
2. Functional App Design
A user-friendly app is one that patients want to use. Health apps aren’t like playing a phone game or ordering food with your phone. However, they should engage users while still delivering the necessary data.
The app should not be too technical for patients. Sometimes simple touches will do the trick. Animation, characters, fonts, and colors all matter—they can make or break the audience’s decision to keep using the app.
3. Clear Objectives
Every companion app has a different purpose. Everyone should know the goal before creating it, as having everyone on the same page makes for less confusion during production.
Without aligned goals established early, the final product may not do its intended job. Plus, if patients see a disorganized app, they will not keep using it. The companion app’s long-term success should have a clear pathway to meet those goals. Creators should plan for the app to change over time so it continues to meet objectives.
4. Device Compatibility
If the app is only compatible with iOS, an entire demographic of Android users will be left out. The companion app should work for everyone, no matter which device they use.
Does the app look or function differently on various devices? What changes should you make so that it works for everyone? Experts who know how to troubleshoot technology issues and fix unexpected problems will be beneficial.
5. A Cohesive Data Collection Platform
While the app creators may have adequately prepared all the visual design details and patients may want to use the app, the app also needs to collect pertinent data. Developers can build a secure platform so that correct data transfers back and forth, depending on what information is required from patients.
The design can also incorporate the research, tools, and intelligence gathering systems to make it cohesive for everyone. It should track patient drug use, prescriber information, and any other points that matter to the specific research.Learn about the critical building blocks to help build a DTx and remote patient monitoring strategy.
Knowing the elements that make up a successful companion app will create a more efficient development process and a more successful drug launch. At PRA, our expertise encompasses all areas of companion app creation.
Responding to the COVID-19 Pandemic in More Ways Than One
PRA’s global response to the COVID-19 pandemic has been thoughtful and deliberate, keeping in mind not only our industry, but all the people our…
Human Centricity Sell Sheet
Sell Sheet containing the business benefit, programs, and competencies.
PRA Health Sciences' 2nd Annual Celebration of World Children’s Day
Children and young adults across the globe are largely underrepresented in clinical research. While legal actions such as the Research to Accelerate…